University of Basrah
  • Register
  • Login
  • العربیة

The Medical Journal of Basrah University

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 39, Issue 1
  3. Authors

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

News

Overview of Iraqi experience in management of acute promyelocytic leukemia

    Waseem Al-Tameemi Zahra’a S. Shakir

The Medical Journal of Basrah University, 2021, Volume 39, Issue 1, Pages 21-30
10.33762/mjbu.2021.129847.1068

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background & Objectives
In Iraq, leukemia is the 4th most common cancer, Acute promyelocytic leukemia contributes to 2.83%, and 3.18% of leukemia in Iraqi males and females respectively. This study is to review of acute promyelocytic leukemia patients presentation and management outcome in Iraq
Patients and Method
A hospital based case series study was conducted over a period of 15 months in different hematology centers. A total of 58 acute promyelocytic leukemia patients were enrolled in this study (53 newly diagnosed and 5 relapsed cases). Diagnosis based on of morphology with or without cytogenetic study.
Results
The mean age was 33.1±13.8 years, with slight female predominance. Most cases presented at winter season (39.7%). Sanz severity scoring classification as; (25.9%) low risk, (53.4%) intermediate risk, and (20.6%) high risk disease. Induction protocol consist of chemotherapy plus ATRA in (58%) while (36.2%) received only ATRA plus ATO. At the end of induction, 86.2% of patients have complete remission, while only 13.8% have failure of induction due to death. Induction mortality was higher in those who have received chemotherapy based regimens. At relapse, a second complete remission has been achieved in 4 out of 5 cases (80%).

Conclusion
There is a predilection of acute promyelocytic leukemia to young age group and winter season presentation. The choice of non-chemotherapy regimens, especially for the low and intermediate risk group, showed no drawback in complete remission rate. Disease outcome in Iraq has improved over several years due to increasing experience with using different regimen
Keywords:
    ACUTE LEUKEMIA,, ,،,؛promylocytic leukemia,, ,،,؛Iraq,, ,،,؛chemotherapy
Main Subjects:
  • Oncology
  • PDF (404 K)
  • XML
(2021). Overview of Iraqi experience in management of acute promyelocytic leukemia. The Medical Journal of Basrah University, 39(1), 21-30. doi: 10.33762/mjbu.2021.129847.1068
Waseem Al-Tameemi; Zahra’a S. Shakir. "Overview of Iraqi experience in management of acute promyelocytic leukemia". The Medical Journal of Basrah University, 39, 1, 2021, 21-30. doi: 10.33762/mjbu.2021.129847.1068
(2021). 'Overview of Iraqi experience in management of acute promyelocytic leukemia', The Medical Journal of Basrah University, 39(1), pp. 21-30. doi: 10.33762/mjbu.2021.129847.1068
Overview of Iraqi experience in management of acute promyelocytic leukemia. The Medical Journal of Basrah University, 2021; 39(1): 21-30. doi: 10.33762/mjbu.2021.129847.1068
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 282
  • PDF Download: 251
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

 
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus